Walgreens Boots Alliance, Inc. (WBA) Total Return CAGR:31.43%(TTM)
Over the latest trailing 12-month period, Walgreens Boots Alliance, Inc. (WBA)'s total return cagr is +31.43%. The comparable SPY value is +24.27%. Year-to-date total return is +28.40%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Walgreens Boots Alliance, Inc.'s Total Return CAGR averages -26.89% over 3 years and -16.99% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Walgreens Boots Alliance, Inc.'s investment performance.
WBA Total Return CAGR Chart
Walgreens Boots Alliance, Inc. (WBA)
WBA Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
WBA Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | 206.36 | 264.97 | +58.61 | +28.40% | +28.40% |
| 2024 | 534.44 | 206.36 | -328.08 | -61.39% | -61.39% |
| 2023 | 713.27 | 534.44 | -178.83 | -25.07% | -25.07% |
| 2022 | 950.98 | 713.27 | -237.71 | -25.00% | -25.00% |
| 2021 | 700.25 | 950.98 | +250.74 | +35.81% | +35.81% |
| 2020 | 990.92 | 700.25 | -290.68 | -29.33% | -29.33% |
| 2019 | 1113.68 | 990.92 | -122.75 | -11.02% | -11.02% |
| 2018 | 1156.16 | 1113.68 | -42.48 | -3.67% | -3.67% |
| 2017 | 1292.23 | 1156.16 | -136.07 | -10.53% | -10.53% |
| 2016 | 1305.62 | 1292.23 | -13.40 | -1.03% | -1.03% |
| 2015 | 1149.08 | 1305.62 | +156.54 | +13.62% | +13.62% |
| 2014 | 849.29 | 1149.08 | +299.79 | +35.30% | +35.30% |
| 2013 | 534.35 | 849.29 | +314.94 | +58.94% | +58.94% |
| 2012 | 463.42 | 534.35 | +70.93 | +15.31% | +15.31% |
| 2011 | 534.58 | 463.42 | -71.16 | -13.31% | -13.31% |
| 2010 | 494.32 | 534.58 | +40.26 | +8.14% | +8.14% |
| 2009 | 326.86 | 494.32 | +167.46 | +51.23% | +51.23% |
| 2008 | 498.08 | 326.86 | -171.21 | -34.37% | -34.37% |
| 2007 | 595.45 | 498.08 | -97.37 | -16.35% | -16.35% |
| 2006 | 570.60 | 595.45 | +24.85 | +4.35% | +4.35% |
| 2005 | 492.14 | 570.60 | +78.46 | +15.94% | +15.94% |
| 2004 | 464.17 | 492.14 | +27.97 | +6.03% | +6.03% |
| 2003 | 370.51 | 464.17 | +93.66 | +25.28% | +25.28% |
| 2002 | 425.52 | 370.51 | -55.01 | -12.93% | -12.93% |
| 2001 | 526.60 | 425.52 | -101.08 | -19.20% | -19.20% |
| 2000 | 366.85 | 526.60 | +159.76 | +43.55% | +43.55% |
| 1999 | 365.47 | 366.85 | +1.38 | +0.38% | +0.38% |
| 1998 | 194.63 | 365.47 | +170.84 | +87.77% | +87.77% |
| 1997 | 123.59 | 194.63 | +71.04 | +57.48% | +57.48% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q3 2025 | 265 | +5.9% | +36.0% |
| Q2 2025 | 250 | +1.4% | -2.2% |
| Q1 2025 | 247 | +20.4% | -41.9% |
| Q4 2024 | 205 | +5.2% | -61.6% |
| Q3 2024 | 195 | -23.9% | -54.6% |
| Q2 2024 | 256 | -39.7% | -58.7% |
| Q1 2024 | 425 | -20.4% | -36.6% |
| Q4 2023 | 533 | +24.4% | -27.1% |
| Q3 2023 | 429 | -30.8% | -30.5% |
| Q2 2023 | 620 | -7.5% | -20.1% |
| Q1 2023 | 670 | -8.4% | -22.2% |
| Q4 2022 | 731 | +18.6% | -23.1% |
| Q3 2022 | 617 | -20.5% | -27.4% |
| Q2 2022 | 776 | -9.8% | -17.5% |
| Q1 2022 | 861 | -9.5% | -8.3% |
| Q4 2021 | 951 | +11.9% | +36.7% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth